FEB 13, 2017 01:54 PM PST

Females More Prone to Disease Due to Key Immunological Difference

WRITTEN BY: Kara Marker

There seems to be a key genetic difference between males and females that is not related to sex chromosomes. Instead, it is a difference in activity between the two sexes in a specific type of immune cell which leaves females more vulnerable to some stress-related and allergic diseases.

The immune cell found in this study to put females at an increased risk for certain diseases is the mast cell. These immune components usually do not circulate in the bloodstream the way other immune cells do. Instead, they exist in tissue types all over the body fulfilling a plethora of roles such as vasodilation, angiogenesis, pathogen elimination, and even maintenance of other immune cells.

From Michigan State University, in a new study published in the journal Biology of Sex Differences, researchers picked apart and examined several genes within the RNA genome. "Over 8,000 differentially expressed genes were found in female mast cells compared to male mast cells," said lead researcher and associate professor Adam Moeser said. "While male and female mast cells have the same sets of genes on their chromosomes, with the exception of the XY sex chromosomes, the way the genes act vary immensely between the sexes."

Specifically, they saw an increase in inflammatory activity linked to mast cells in females that causes a more intense immune response to stress and allergy, resulting in diseases like irritable bowel syndrome (IBS). Doctors aren’t sure what causes IBS, but the associated symptoms seem to be consistent: abdominal pain and discomfort, changes in bowel movements, and bloating.

With this research completed, transitioning to sex-specific treatments that directly target mast cells in females specifically is definitely something that will be considered. The next question Moeser and his team will have to answer though is this: at what point to mast cells begin to act differently between males and females?

“Pinpointing when this variance happens will let us know if it occurs during adulthood or in individuals at an early age," Moeser said. "Many mast cell diseases exhibit a sex bias in children and if we can identify the timing and the mechanism of what's influencing the change, we'll have an even better understanding of how these immune cells cause disease and know when to intervene with potentially new therapies."

Sources: Michigan State University, Frontiers in Immunology, National Institute of Diabetes and Digestive and Kidney Diseases

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 29, 2018
Immunology
AUG 29, 2018
Immune System Prioritizes Response when Faced with Multiple Threats
The Innate Immune response prioritizes lung infection and cell repair over other threats in both infants and adults....
SEP 07, 2018
Health & Medicine
SEP 07, 2018
What's Behind the Massive Measles Outbreak in Europe?
Measles is a disease that many believe was eradicated years ago. That's true, to a point, but like a bad penny, it's back. In the United States, th...
NOV 13, 2018
Immunology
NOV 13, 2018
Bacteria Offers Solution to Inflammation
A team of researchers surveys the mutualistic relationship between gut bacteria and host in regards to gut inflammation in zebrafish...
NOV 13, 2018
Immunology
NOV 13, 2018
Yin & Yang: The Duality of Cancer-Associated Fibroblasts in Pancreatic Cancer
Pancreatic Cancer is a devastating disease. Fifty-five thousand new patients were diagnosed this year in the United States (1). It is painful and usua...
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Anti-inflammatory Drug Works Like an Inhibitor
At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor. The new anti-...
Loading Comments...